Climacteric

Papers
(The H4-Index of Climacteric is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Peer reviewers for Climacteric in 2024119
Variations in the prevalence of premature and early menopause in low and middle-income regions: a cross-sectional study70
Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted46
Safety and acceptability of intravaginal rings releasing estradiol and progesterone45
Expanding knowledge across medical specialties in menopause research and practice: why it is so important for women’s health41
Effects of jazz dance and concurrent training on physical variables in postmenopausal women40
Influence of estradiol deficiency on the mineralocorticoid receptor response in postmenopausal women: a cross-sectional study33
Low thrombin generation in postmenopausal women using estetrol33
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women32
Peer reviewers for Climacteric in 202229
Awareness of menopause and menopause hormone therapy in India: perspectives of healthcare providers and consumers29
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy25
Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia25
Women’s experience and management of cognition during menopause transition: a qualitative study25
The musculoskeletal syndrome of menopause23
Androgen therapy in midlife and older women: a position statement of the Latin American Association of Gynecological Endocrinology (ALEG)23
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China21
Quo vadis?20
‘Menopausando’: a digital health education platform for women in the transition to menopause and postmenopause19
0.10507202148438